Real-time enrollment status for this congenital hyperinsulinism clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT06208215 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Congenital Hyperinsulinism |
| Phase | Clinical Trial |
| Target Enrollment | 56 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Rezolute |
| Last Updated on CT.gov | January 8, 2026 (Jan 8, 2026) |
As of March 2, 2026: Clinical trial NCT06208215 is currently active_not_recruiting participants. This clinical trial study for congenital hyperinsulinism is not currently accepting new participants at 2 locations across the United States. The study is sponsored by Rezolute. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06208215 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06208215 was last updated Jan 8, 2026 (January 8, 2026). HelloStudys verifies this status automatically.